USA - New York Stock Exchange - NYSE:SOLV - US83444M1018 - Common Stock
The current stock price of SOLV is 78.96 USD. In the past month the price decreased by -2.13%. In the past year, price increased by 5.29%.
ChartMill assigns a technical rating of 6 / 10 to SOLV. When comparing the yearly performance of all stocks, SOLV turns out to be only a medium performer in the overall market: it outperformed 69.96% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to SOLV. SOLV has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months SOLV reported a non-GAAP Earnings per Share(EPS) of 5.94. The EPS increased by 108.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.14% | ||
| ROA | 10.91% | ||
| ROE | 30.57% | ||
| Debt/Equity | 1.03 |
21 analysts have analysed SOLV and the average price target is 90.42 USD. This implies a price increase of 14.51% is expected in the next year compared to the current price of 78.96.
For the next year, analysts expect an EPS growth of -8.17% and a revenue growth 0.5% for SOLV
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.52 | 16.03B | ||
| ALGN | ALIGN TECHNOLOGY INC | 17.12 | 11.88B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 21.96 | 4.84B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.05 | 4.37B | ||
| ICUI | ICU MEDICAL INC | 19.25 | 3.78B | ||
| HAE | HAEMONETICS CORP/MASS | 14.6 | 3.28B | ||
| XRAY | DENTSPLY SIRONA INC | 7.63 | 2.40B | ||
| NEOG | NEOGEN CORP | 32.24 | 2.03B | ||
| UFPT | UFP TECHNOLOGIES INC | 30.39 | 2.02B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.04B | ||
| EMBC | EMBECTA CORP | 4.14 | 719.09M | ||
| BVS | BIOVENTUS INC - A | 13.07 | 638.08M |
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 22,000 full-time employees. The company went IPO on 2024-03-26. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
SOLVENTUM CORP
C/O 3M Company, 3M Center, Building 275-6W-02
ST. PAUL MINNESOTA US
Employees: 22000
Phone: 16517331110
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 22,000 full-time employees. The company went IPO on 2024-03-26. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
The current stock price of SOLV is 78.96 USD. The price decreased by -0.65% in the last trading session.
SOLV does not pay a dividend.
SOLV has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
SOLVENTUM CORP (SOLV) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
SOLVENTUM CORP (SOLV) will report earnings on 2026-02-23, before the market open.
You can find the ownership structure of SOLVENTUM CORP (SOLV) on the Ownership tab.